The Neuro4D is a focused and highly interactive international conference on Neuro Degenerative Disease Drug Discovery, bringing together drug discovery companies, service and technology providers, and academic innovators in the field of proteopathic neurodegenerative diseases.
Neuro4D brings a limited number of distinguished industry and academic speakers, poster presenters and delegates in neurodegenerative disease in direct contact, and creates lively discussions about drug discovery efforts for two full days, in a stimulating and enjoyable setting. Academic research leaders outline recent findings and insights into the complex disease mechanisms. Biotech and international pharmaceutical drug companies present their developments for new treatment options and outline advantages and disadvantages of models and technologies used for compound selection and optimization. Service and technology providers present their platforms and show examples of how their services contribute to the discovery of new drug candidates. By the end of the conference, all participants get to know each other, prompting productive collaborations.
In 2024 we will unify our previous and new participants again in the inspiring environment of Mainz, Germany. The conference will stick to the successful session format and chairperson leadership. Each speaker has 15 min for presentation and Q&A, as they decide, and will participate in a podium discussion with all speakers at the end of each session. This year we will focus on Parkinson’s disease, ALS, Huntington’s disease, etc. for our conference on proteopathic neurodegenerative diseases.
- Target Audience:
- Drug discovery experts from biotech and pharmaceutical industry
- Academic experts in proteopathic neurodegenerative diseases interested in drug discovery
- Service providers and users of up-to-date drug discovery technologies, analytical tools, and models of neurodegeneration
- Pharma strategists and investors interested in the field and prepared to fund the most innovative approaches
- PhDs looking for new positions in the field
